ProCE Banner Activity

Optimizing Treatment for Patients With HR-Positive/HER2-Negative MBC

Slideset

Downloadable slideset on the current treatment algorithm, guidelines and evidence-based approaches for the optimal integration of CDK4/6 inhibitors in the management of patients with HR-positive/HER2-negative metastatic breast cancer with careful consideration of patients’ preexisting comorbidities, concomitant medications, and goals of care.

Released: March 21, 2025

Expiration: March 20, 2026

Share

Provided by

Provided by Clinical Care Options, LLC., in partnership with Practicing Clinicians Exchange (PCE) and ProCE, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer Inc.

Partners

Practicing Clinicians Exchange

ProCE Banner

ProCE, LLC

ProCE Banner